Literature DB >> 24054985

Prevalence of borreliosis, anaplasmosis, ehrlichiosis and Dirofilaria immitis in dogs and vectors in Voronezh Reserve (Russia).

N S Volgina1, B V Romashov, N B Romashova, A V Shtannikov.   

Abstract

Most of the dogs studied for the prevalence of CVBD have previously received acaricidal and insecticidal treatments. In the present work, a very specific population of dogs (Group 1) that had never been treated against ticks and mosquitoes was studied. Moreover, the territory occupied by this population has also never been treated, because it is a protected area--Voronezh Natural Reserve. Canine patients from veterinary clinics (Group 2) that had been treated against VBD vectors were studied for comparison. Eighty-two dogs (Group 1) were enrolled in June, 2008. Blood samples were tested using the IDEXX SNAP(®) 4Dx(®) test. A specific heartworm antigen was detected in 12.2% samples. The seroprevalence for Anaplasma phagocytophilum was found to be 34.1%. The antibodies to Borrelia C6 peptide and to Ehrlichia canis were detected in 2.4% of the samples. Almost all dogs with infections had no clinical signs. Only 3 mixed-infected dogs showed non-specific clinical signs. During the tick season, 358 Ixodes ricinus were collected; the prevalence of Borrelia burgdorferi s.l. and Anaplasma phagocytophilum was 21.9% and 0.6%, respectively. Four hundred and forty dogs (Group 2) were studied for comparison. Antibodies to B. burgdorferi s.l. were detected only in one dog, seroprevalence for A. phagocytophilum represented 1.1%, no E. canis seropositive dogs were identified, and 8.2% dogs were found infected with Dirofilaria immitis. Fifty-six percent of dogs with dirofilariosis had clinical signs. All dogs with anaplasmosis showed specific clinical signs--fever, anemia, splenitis. Three dogs died within a few days.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anaplasmosis; Dirofilariosis; Dogs; Ehrlichiosis; Lyme disease

Mesh:

Year:  2013        PMID: 24054985     DOI: 10.1016/j.cimid.2013.08.003

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  6 in total

1.  Current Surveys of the Seroprevalence of Borrelia burgdorferi, Ehrlichia canis, Anaplasma phagocytophilum, Leishmania infantum, Babesia canis, Angiostrongylus vasorum and Dirofilaria immitis in Dogs in Bulgaria.

Authors:  Nikola Pantchev; Manuela Schnyder; Majda Globokar Vrhovec; Roland Schaper; Ilia Tsachev
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

2.  Comparative analysis of the infectivity rate of both Borrelia burgdorferi and Anaplasma phagocytophilum in humans and dogs in a New Jersey community.

Authors:  Andrea Gaito; Vedrana Gjivoje; Sebastian Lutz; Ben Baxter
Journal:  Infect Drug Resist       Date:  2014-08-07       Impact factor: 4.003

Review 3.  Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe.

Authors:  Ángel Sainz; Xavier Roura; Guadalupe Miró; Agustín Estrada-Peña; Barbara Kohn; Shimon Harrus; Laia Solano-Gallego
Journal:  Parasit Vectors       Date:  2015-02-04       Impact factor: 3.876

4.  Countrywide serological evaluation of canine prevalence for Anaplasma spp., Borrelia burgdorferi (sensu lato), Dirofilaria immitis and Ehrlichia canis in Mexico.

Authors:  Rebeca Movilla; Carlos García; Susanne Siebert; Xavier Roura
Journal:  Parasit Vectors       Date:  2016-07-29       Impact factor: 3.876

5.  Serological evidence of Anaplasma spp., Borrelia burgdorferi and Ehrlichia canis in dogs from the Republic of Korea by rapid diagnostic test kits.

Authors:  Evelyn Alejandra Miranda; Sun-Woo Han; Ji-Min Rim; Yoon-Kyoung Cho; Kyoung-Seong Choi; Joon-Seok Chae
Journal:  J Vet Sci       Date:  2022-01-07       Impact factor: 1.672

Review 6.  Epidemiological and Clinicopathological Features of Anaplasma phagocytophilum Infection in Dogs: A Systematic Review.

Authors:  Sarah El Hamiani Khatat; Sylvie Daminet; Luc Duchateau; Latifa Elhachimi; Malika Kachani; Hamid Sahibi
Journal:  Front Vet Sci       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.